Ticker
TNXPCompany Name
TONIX PHARMACEUTICALS HOLDING CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 143.53M | $ 5.99M | $ 19.06M | 7.22 |
3/31/2025 | $ 149.57M | $ 8.14M | $ 12.15M | 11.64 |
12/31/2024 | $ 119M | $ 8.41M | $ 18.31M | 6.04 |
9/30/2024 | $ 50.54M | $ 7.93M | $ 15.18M | 2.81 |
6/30/2024 | $ 25.29M | $ 9.46M | $ 22.04M | 0.72 |
3/31/2024 | $ 30.1M | $ 12.35M | $ 20.48M | 0.87 |
12/31/2023 | $ 47.77M | $ 13.64M | $ 18.88M | 1.81 |
9/30/2023 | $ 31.34M | $ 13.32M | $ 17.73M | 1.02 |
6/30/2023 | $ 51.33M | $ 13.7M | $ 18.44M | 2.04 |
3/31/2023 | $ 83.73M | $ 0 | $ 13.07M | 6.4 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: (AssetsC [ $ 62.02M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 4.38M ]
(=) Quick Ratio [ 14.17 ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |